Prescription drug · ANDA
Migergot (Ergotamine tartrate and caffeine) NDC 0713-0166
Ergotamine tartrate 2 mg/1; Caffeine 100 mg/1 · Suppository · Rectal · Cosette Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0713-0166-12 | 0071301661200713016612 | 12 SUPPOSITORY in 1 BOX (0713-0166-12)Marketed from Oct 30, 1983 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Migergot
- Generic name (nonproprietary)
- ergotamine tartrate and caffeine
- Active ingredients
- Ergotamine tartrate — 2 mg/1Caffeine — 100 mg/1
- Dosage form
- Suppository
- Route
- Rectal
- Labeler
- Cosette Pharmaceuticals, Inc.NDC labeler code 0713
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 086557
- Marketing start
- Listing expires
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)Ergotamines (Chemical structure)Xanthines (Chemical structure)
- Identifiers
- Product ID 0713-0166_ee9c58f6-c353-2cf3-e053-2a95a90a3f5eSPL ID ee9c58f6-c353-2cf3-e053-2a95a90a3f5eSPL set ID 3a31ad0c-7bdd-544b-f5df-a99d04cf541cRxCUI 1293508, 1293639UNII MRU5XH3B48, 3G6A5W338E
- Pharmacologic class
- Central Nervous System Stimulant; Ergotamine Derivative; Methylxanthine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400713016612followed by a unit qualifier and the quantityPackage 00713-0166-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Ergotamine Tartrate and Caffeine Indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called “histaminic cephalalgia”.
Excerpt only. Read the full label for complete information.
About NDC 0713-0166
- What is NDC 0713-0166?
- 0713-0166 is the product NDC for Migergot, Ergotamine tartrate 2 mg/1; Caffeine 100 mg/1 suppository, listed with the FDA by Cosette Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Migergot (Ergotamine Tartrate and Caffeine).
- What is the active ingredient?
- Ergotamine tartrate, Caffeine.
- Who is the labeler?
- Cosette Pharmaceuticals, Inc., NDC labeler code 0713. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Migergot?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.